Advanced Studies in Oncology Webcast: Evidenced based management of Chemotherapy Induced Febrile Neutropenia

define: Febrile neutropenia: the development of fever, often with other signs of infection


link to webcast

NKTR-102 Phase 2 Clinical Data Accepted for Oral Presentation at 2010 ASCO... -- SAN CARLOS, Calif., May 20 /PRNewswire-FirstCall/ --

Nektar To Host Investor Breakfast at ASCO on Monday, June 7, 2010

Nektar will also webcast a presentation to investors and analysts to be held at the 2010 ASCO Meeting on Monday, June 7, 2010 at 8 AM Central Time.

Panelists at the investor event will include:

* Ignace Vergote, M.D., Ph.D., Head of the Department of Obstetrics and Gynaecology and Gynaecologic Oncology at the Catholic University of Leuven, Belgium;
* Robert Coleman, M.D., Director of Clinical Research, Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and
* Daniel Von Hoff, M.D., F.A.C.P., Chief Scientific Officer, TGen Clinical Research Services at Scottsdale Healthcare and U.S. Oncology, and Clinical Professor of Medicine at the University of Arizona College of Medicine and 2010 recipient of the ASCO David A. Karnofsky Memorial Award Lecture.


The event will be accessible live and by replay and can be accessed from the homepage of the company's website at www.nektar.com beginning on June 7, 2010 at 8:00 AM Central Time.

Webcast/CME - Institute for Continuing Healthcare Education - Ovarian Cancer Screening and Management to Improve Patient Survival Apr 16, 2010

Webast/CME
OVERVIEW
Ovarian cancer is the leading cause of death from gynecologic malignancy and the fifth leading cause of cancer‐related death among women in the United States. The high mortality rate associated with ovarian cancer is due in part to the lack of effective screening strategies to detect the disease in early stages (I or II) when the cancer is confined to the ovary. Since symptoms associated with ovarian cancer are typically nonspecific, a clinical diagnosis is difficult to make until the disease has advanced. The Institute for Continuing Healthcare Education has identified a number of areas related to the screening, diagnosis, and treatment of ovarian cancer where education is vital in order to address the need for improvement in professional care.

Webcast: Clinical Trials and Translational Research - info on NCI's clinical trials/public meetings

The Clinical Trials and Translational Research Advisory Committee (CTAC) meets three times annually to provide strategic advice regarding NCI’s clinical trials and translational research portfolio and processes. In order to make this dialogue transparent and available to the public these meetings will be webcast at http://videocast.nih.gov/. The next meeting is scheduled for Wednesday, March 10th from 8a to 3:30pm. We encourage you to tune in and learn more. This meeting will include: · A report from the Operational Efficiency Working Group on how to make the clinical research process more efficient · An update from the NCI Director · An update on Comparative Effectiveness Research (CER) funding and a future vision for CER and Cancer · Information about the new NCI Cancer Human Biobank or caHUB A full agenda is available at http://deainfo.nci.nih.gov/advisory/ctac/0310/agenda.pdf. Shannon K. Bell, MSW Director, Office of Advocacy Relations, NCI Bldg 31 Rm 10A28, 301-451-3393 Key info about NCI: http://www.cancer.gov/aboutNCI/servingpeople